Toth Financial Advisory’s Idexx Laboratories IDXX Stock Holding History

Toth Financial Advisory’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$2.5K	–	828
2023 Q1	$2.5K	Buy	+5	New	+$2.39K	﹤0.01%	624
2019 Q4	–	Sell	-1,050	Closed	-$286K	–	501
2019 Q3	$286K	Hold	1,050	–	–	0.06%	144
2019 Q2	$289K	Buy	+1,050	New	+$259K	0.06%	145

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Toth Financial Advisory's IDXX Position: Q2 2023 in Review

Toth Financial Advisory sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 5 shares — an estimated $2.5K sold.

Toth Financial Advisory first reported a position in IDXX in Q2 2019 and held it in 3 quarters. The position peaked at $289K in Q2 2019. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Toth Financial Advisory reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
Toth Financial Advisory sold 5 Idexx Laboratories shares in Q2 2023, an estimated $2.5K.
Toth Financial Advisory first reported a position in Idexx Laboratories in Q2 2019 and held it in 3 quarters.
Toth Financial Advisory's Idexx Laboratories position peaked at $289K in Q2 2019.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Toth Financial Advisory's 13F filing for Q2 2023, filed 24 Jul 2023.